To direct treatment decisions by drug sensitivity testing (DST), this study compared several methods for tumor cell isolation from malignant effusions, pointing to repeated CD45+ cell depletion for effective tumor cell isolation, yielding DST results that correlated with clinical outcomes. This evidence concerns the gene PTPRC and neoplasm.